Epidemiological analyses to inform stroke clinical practice
guidelines development

J 2019

Epidemiological analyses to inform stroke clinical practice guidelines development

LÍČENÍK, Radim, Jitka KLUGAROVÁ, Andrea POKORNÁ, Monika BEZDĚKOVÁ, Jiří JARKOVSKÝ et. al.

Základní údaje

Originální název

Epidemiological analyses to inform stroke clinical practice guidelines development

Autoři

LÍČENÍK, Radim (203 Česká republika, domácí), Jitka KLUGAROVÁ (203 Česká republika, domácí), Andrea POKORNÁ (203 Česká republika, garant, domácí), Monika BEZDĚKOVÁ (203 Česká republika, domácí), Jiří JARKOVSKÝ (203 Česká republika, domácí), Petra BÚŘILOVÁ (203 Česká republika, domácí), Tomáš NEČAS (203 Česká republika), Jan MUŽÍK (203 Česká republika, domácí), Silvie ŠEBESTOVÁ (203 Česká republika), Dana DOLANOVÁ (703 Slovensko, domácí), Martin HUNČOVSKÝ (203 Česká republika), Ladislav DUŠEK (203 Česká republika, domácí) a Miloslav KLUGAR (203 Česká republika, domácí)

Vydání

International Journal of Evidence-Based Healthcare, Wolters Kluwer/Lippincott Williams & Wilkins, 2019, 1744-1609

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 1.930

Kód RIV

RIV/00216224:14110/19:00110132

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1097/XEB.0000000000000189

UT WoS

000511111600017

Klíčová slova anglicky

aortic valve disease; atrial fibrillation; atrial septal defect; clinical practice guidelines; endocarditis; flutter; intravenous thrombolysis; ischaemic stroke; mechanical thrombectomy; secondary prevention

Štítky

14110611, 14119612, 14119613, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 11. 5. 2020 09:29, Mgr. Tereza Miškechová

Anotace

V originále

Stroke is one of the leading causes of mortality and the leading cause of functional impairment and cognitive deficits worldwide. It is important that clinical practice guidelines development is based on robust statistical and epidemiological data and their analysis throughout the whole process of guidelines development and implementation. The aim of this short communication is to analyse epidemiology of prevalence and incidence of ischaemic stroke, its main causes, brain imaging using MRI, recanalization therapies, secondary prevention with antiplatelet and anticoagulants, mortality data and to inform development of stroke clinical practice guidelines in the Czech Republic. The main analysed diagnosis was I63 (cerebral infarction) and secondary diagnoses were: I48 (atrial fibrillation and flutter), I35.9 (nonspecified aortic valve disease), Q21.1 (atrial septal defect) or I33.0 (acute and subacute endocarditis). We have also analysed use of brain imaging with MRI, recanalization treatment using intravenous thrombolysis and mechanical thrombectomy, stroke secondary prevention with antiplatelet drugs and anticoagulation as well as hospital admissions and mortality. In total, 159 344 patients were diagnosed with an ischaemic stroke from 2015 to 2017. Average prevalence of ischaemic stroke in the Czech Republic is 54.9 patients per 100 000. 22.2% of patients with stroke received intravenous thrombolysis or mechanical thrombectomy in 2017.

Citovat

LÍČENÍK, Radim, Jitka KLUGAROVÁ, Andrea POKORNÁ, Monika BEZDĚKOVÁ, Jiří JARKOVSKÝ, Petra BÚŘILOVÁ, Tomáš NEČAS, Jan MUŽÍK, Silvie ŠEBESTOVÁ, Dana DOLANOVÁ, Martin HUNČOVSKÝ, Ladislav DUŠEK a Miloslav KLUGAR. Epidemiological analyses to inform stroke clinical practice guidelines development. International Journal of Evidence-Based Healthcare. Wolters Kluwer/Lippincott Williams & Wilkins, 2019, roč. 17, Supplement 1, s. „S53“-„S56“, 4 s. ISSN 1744-1609. Dostupné z: https://dx.doi.org/10.1097/XEB.0000000000000189.

@article{1545144,
   author = {Líčeník, Radim and Klugarová, Jitka and Pokorná, Andrea and Bezděková, Monika and Jarkovský, Jiří and Búřilová, Petra and Nečas, Tomáš and Mužík, Jan and Šebestová, Silvie and Dolanová, Dana and Hunčovský, Martin and Dušek, Ladislav and Klugar, Miloslav},
   article_number = {Supplement 1},
   doi = {http://dx.doi.org/10.1097/XEB.0000000000000189},
   keywords = {aortic valve disease; atrial fibrillation; atrial septal defect; clinical practice guidelines; endocarditis; flutter; intravenous thrombolysis; ischaemic stroke; mechanical thrombectomy; secondary prevention},
   language = {eng},
   issn = {1744-1609},
   journal = {International Journal of Evidence-Based Healthcare},
   title = {Epidemiological analyses to inform stroke clinical practice guidelines development},
   url = {http://dx.doi.org/10.1097/XEB.0000000000000189},
   volume = {17},
   year = {2019}
}

TY  - JOUR
ID  - 1545144
AU  - Líčeník, Radim - Klugarová, Jitka - Pokorná, Andrea - Bezděková, Monika - Jarkovský, Jiří - Búřilová, Petra - Nečas, Tomáš - Mužík, Jan - Šebestová, Silvie - Dolanová, Dana - Hunčovský, Martin - Dušek, Ladislav - Klugar, Miloslav
PY  - 2019
TI  - Epidemiological analyses to inform stroke clinical practice guidelines development
JF  - International Journal of Evidence-Based Healthcare
VL  - 17
IS  - Supplement 1
SP  - „S53“-„S56“
EP  - „S53“-„S56“
PB  - Wolters Kluwer/Lippincott Williams & Wilkins
SN  - 17441609
KW  - aortic valve disease
KW  - atrial fibrillation
KW  - atrial septal defect
KW  - clinical practice guidelines
KW  - endocarditis
KW  - flutter
KW  - intravenous thrombolysis
KW  - ischaemic stroke
KW  - mechanical thrombectomy
KW  - secondary prevention
UR  - http://dx.doi.org/10.1097/XEB.0000000000000189
L2  - http://dx.doi.org/10.1097/XEB.0000000000000189
N2  - Stroke is one of the leading causes of mortality and the leading cause of functional impairment and cognitive deficits worldwide. It is important that clinical practice guidelines development is based on robust statistical and epidemiological data and their analysis throughout the whole process of guidelines development and implementation. The aim of this short communication is to analyse epidemiology of prevalence and incidence of ischaemic stroke, its main causes, brain imaging using MRI, recanalization therapies, secondary prevention with antiplatelet and anticoagulants, mortality data and to inform development of stroke clinical practice guidelines in the Czech Republic. The main analysed diagnosis was I63 (cerebral infarction) and secondary diagnoses were: I48 (atrial fibrillation and flutter), I35.9 (nonspecified aortic valve disease), Q21.1 (atrial septal defect) or I33.0 (acute and subacute endocarditis). We have also analysed use of brain imaging with MRI, recanalization treatment using intravenous thrombolysis and mechanical thrombectomy, stroke secondary prevention with antiplatelet drugs and anticoagulation as well as hospital admissions and mortality. In total, 159 344 patients were diagnosed with an ischaemic stroke from 2015 to 2017. Average prevalence of ischaemic stroke in the Czech Republic is 54.9 patients per 100 000. 22.2% of patients with stroke received intravenous thrombolysis or mechanical thrombectomy in 2017.
ER  -

LÍČENÍK, Radim, Jitka KLUGAROVÁ, Andrea POKORNÁ, Monika BEZDĚKOVÁ, Jiří JARKOVSKÝ, Petra BÚŘILOVÁ, Tomáš NEČAS, Jan MUŽÍK, Silvie ŠEBESTOVÁ, Dana DOLANOVÁ, Martin HUNČOVSKÝ, Ladislav DUŠEK a Miloslav KLUGAR. Epidemiological analyses to inform stroke clinical practice guidelines development. \textit{International Journal of Evidence-Based Healthcare}. Wolters Kluwer/Lippincott Williams \&{} Wilkins, 2019, roč.~17, Supplement 1, s.~„S53“-„S56“, 4 s. ISSN~1744-1609. Dostupné z: https://dx.doi.org/10.1097/XEB.0000000000000189.

Podrobný výpis o publikaci